Skip to main content
Erschienen in: Osteoporosis International 3/2017

20.10.2016 | Original Article

Increased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density

verfasst von: C. Tsentidis, D. Gourgiotis, L. Kossiva, A. Marmarinos, A. Doulgeraki, K. Karavanaki

Erschienen in: Osteoporosis International | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Summary

Higher levels of Dickkopf-1, which is an inhibitor of Wnt/β-catenin bone metabolic pathway, could be indicative of downregulated Wnt system, with possible lower osteoblast activation and higher osteoclast signaling in type 1 diabetes mellitus children and adolescents. Dickkopf-1 could significantly contribute to diabetes osteopathy.

Introduction

Increased fracture risk and elevated Dickkopf-1 levels, which is an inhibitor of Wnt/β-catenin bone metabolic pathway, have been documented in adult patients with type 2 diabetes mellitus (T2D), while no relevant data exist on childhood type 1 diabetes (T1D). Our aim was to study plasma Dickkopf-1 distribution in children and adolescents with T1D and to correlate Dickkopf-1 with metabolic bone markers and bone mineral density (BMD).

Methods

We evaluated 40 children and adolescents with T1D (mean ± SD age 13.04 ± 3.53 years, T1D duration 5.15 ± 3.33 years) and 40 healthy age-matched and gender-matched controls (age 12.99 ± 3.3 years). Dickkopf-1 and bone metabolic markers were measured, while total body and lumbar spine BMD were evaluated with dual-energy X-ray absorptiometry (DXA).

Results

Dickkopf-1 demonstrated a Gaussian distribution, with higher levels in T1D patients (13.56 ± 5.34 vs 11.35 ± 3.76 pmol/L, p = 0.024). Higher values were found in boys and in prepubertal children. Dickkopf-1 correlated positively with osteoprotegerin and fasting glucose in patients, while positive correlation with sclerostin and total soluble receptor activator of nuclear factor-kappaB ligand (s-RANKL) was found in controls. Positive correlations with C-telopeptide cross-links (CTX), osteocalcin, alkaline phosphatase, phosphate, and insulin-like growth factor 1 (IGF1) were documented in both groups. Lumbar spine Z-score was positively associated with Dickkopf-1 in controls, while a negative trend was found in patients.

Conclusions

Higher levels of Dickkopf-1 could indicate a downregulated Wnt/β-catenin system with possible lower osteoblast activation and higher osteoclast signaling in T1D children and adolescents. Dickkopf-1 could possibly be a significant contributor of T1D osteopathy. Future therapies could focus on Wnt/β-catenin metabolic pathway.
Literatur
1.
Zurück zum Zitat Rakel A, Sheehy O, Rahme E, LeLorier J (2008) Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab 34:193–205CrossRefPubMed Rakel A, Sheehy O, Rahme E, LeLorier J (2008) Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab 34:193–205CrossRefPubMed
2.
Zurück zum Zitat Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 18:427–444CrossRef Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 18:427–444CrossRef
4.
Zurück zum Zitat Starup-Linde J (2013) Diabetes, biochemical markers of bone turnover, diabetes control, and bone. Front Endocrinol 4:21CrossRef Starup-Linde J (2013) Diabetes, biochemical markers of bone turnover, diabetes control, and bone. Front Endocrinol 4:21CrossRef
6.
Zurück zum Zitat Yavropoulou MP, Yovos JG (2007) The role of the wnt signaling pathway in osteoblast commitment and differentiation. Hormones 6:279–294CrossRefPubMed Yavropoulou MP, Yovos JG (2007) The role of the wnt signaling pathway in osteoblast commitment and differentiation. Hormones 6:279–294CrossRefPubMed
7.
Zurück zum Zitat Nishimura R, Hata K, Ikeda F, Ichida F, Shimoyama A, Matsubara T, Wada M, Amano K, Yoneda T (2008) Signal transduction and transcriptional regulation during mesenchymal cell differentiation. J Bone Miner Metab 26:203–212CrossRefPubMed Nishimura R, Hata K, Ikeda F, Ichida F, Shimoyama A, Matsubara T, Wada M, Amano K, Yoneda T (2008) Signal transduction and transcriptional regulation during mesenchymal cell differentiation. J Bone Miner Metab 26:203–212CrossRefPubMed
9.
Zurück zum Zitat MacDonald B, Joiner D, Oyserman S, Sharma P, Goldstein S, He X, PV. H (2007) Bone mass is inversely proportional to Dkk1 levels in mice. Bone 41:331–339CrossRefPubMedPubMedCentral MacDonald B, Joiner D, Oyserman S, Sharma P, Goldstein S, He X, PV. H (2007) Bone mass is inversely proportional to Dkk1 levels in mice. Bone 41:331–339CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Grotewold L, Ruther U (2002) THe wnt antagonist dickkopf-1 is regulated by bmp signaling and c-Jun and modulates programmed cell death. EMBO J 21:966–975CrossRefPubMedPubMedCentral Grotewold L, Ruther U (2002) THe wnt antagonist dickkopf-1 is regulated by bmp signaling and c-Jun and modulates programmed cell death. EMBO J 21:966–975CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Choi HY, Dieckmann M, Herz J, Niemeier A (2009) Lrp4, a novel receptor for dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PLoS One 4:e7930CrossRefPubMedPubMedCentral Choi HY, Dieckmann M, Herz J, Niemeier A (2009) Lrp4, a novel receptor for dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PLoS One 4:e7930CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Balemans W, Piters E, Cleiren E, m A, Van Wesenbeeck L, Warman M, Van Hul W (2008) The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone nass LRP5. Calcif Tissue Int 82:445–453CrossRefPubMed Balemans W, Piters E, Cleiren E, m A, Van Wesenbeeck L, Warman M, Van Hul W (2008) The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone nass LRP5. Calcif Tissue Int 82:445–453CrossRefPubMed
13.
Zurück zum Zitat Gaur T, Lengner CJ, Hovhannisyan H et al (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 Gene expression. J Biol Chem 280:33132–33140CrossRefPubMed Gaur T, Lengner CJ, Hovhannisyan H et al (2005) Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 Gene expression. J Biol Chem 280:33132–33140CrossRefPubMed
14.
Zurück zum Zitat Fowlkes J, Bunn R, Liu L, Wahl E, Coleman H, Cockrell G, Perrien D, Lumpkin CJ, Thrailkill K (2008) Runt-related transcription factor 2 (RUNX2) and RUNX2-related Osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus. Endocrinology 149:1697–1704CrossRefPubMed Fowlkes J, Bunn R, Liu L, Wahl E, Coleman H, Cockrell G, Perrien D, Lumpkin CJ, Thrailkill K (2008) Runt-related transcription factor 2 (RUNX2) and RUNX2-related Osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus. Endocrinology 149:1697–1704CrossRefPubMed
15.
Zurück zum Zitat Portal-Nunez S, Lozano D, de Castro LF, de Gortazar AR, Nogues X, Esbrit P (2010) Alterations of the wnt/beta-catenin pathway and its target genes for the N- and C-terminal domains of parathyroid hormone-related protein in bone from diabetic mice. FEBS Lett 584:3095–3100CrossRefPubMed Portal-Nunez S, Lozano D, de Castro LF, de Gortazar AR, Nogues X, Esbrit P (2010) Alterations of the wnt/beta-catenin pathway and its target genes for the N- and C-terminal domains of parathyroid hormone-related protein in bone from diabetic mice. FEBS Lett 584:3095–3100CrossRefPubMed
16.
Zurück zum Zitat Hie M, Iitsuka N, Otsuka T, Tsukamoto I (2011) Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int J Mol Med 28:455–462PubMed Hie M, Iitsuka N, Otsuka T, Tsukamoto I (2011) Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int J Mol Med 28:455–462PubMed
17.
Zurück zum Zitat Gaudio A, Privitera F, Pulvirenti I, Canzonieri E, Rapisarda R, Fiore CE (2014) The relationship between inhibitors of the wnt signalling pathway (sclerostin and dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus. Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 11:48–52CrossRef Gaudio A, Privitera F, Pulvirenti I, Canzonieri E, Rapisarda R, Fiore CE (2014) The relationship between inhibitors of the wnt signalling pathway (sclerostin and dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus. Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 11:48–52CrossRef
18.
Zurück zum Zitat Garcia-Martin A, Reyes-Garcia R, Garcia-Fontana B, Morales-Santana S, Coto-Montes A, Munoz-Garach M, Rozas-Moreno P, Munoz-Torres M (2014) Relationship of Dickkopf1 (DKK1) with cardiovascular disease and bone metabolism in Caucasian type 2 diabetes mellitus. PLoS One 9:e111703CrossRefPubMedPubMedCentral Garcia-Martin A, Reyes-Garcia R, Garcia-Fontana B, Morales-Santana S, Coto-Montes A, Munoz-Garach M, Rozas-Moreno P, Munoz-Torres M (2014) Relationship of Dickkopf1 (DKK1) with cardiovascular disease and bone metabolism in Caucasian type 2 diabetes mellitus. PLoS One 9:e111703CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Lattanzio S, Santilli F, Liani R, Vazzana N, Ueland T, Di Fulvio P, Formoso G, Consoli A, Aukrust P, Davi G (2014) Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. J Am Heart Assoc 3 Lattanzio S, Santilli F, Liani R, Vazzana N, Ueland T, Di Fulvio P, Formoso G, Consoli A, Aukrust P, Davi G (2014) Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. J Am Heart Assoc 3
20.
Zurück zum Zitat Register TC, Hruska KA, Divers J et al (2013) Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J Clin Endocrinol Metab 98:E60–E65CrossRefPubMed Register TC, Hruska KA, Divers J et al (2013) Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes. J Clin Endocrinol Metab 98:E60–E65CrossRefPubMed
21.
Zurück zum Zitat Qiu F, He J, Zhou Y, Bai X, Wu G, Wang X, Liu Z, Chen Y, Ma JX, Liu Z (2014) Plasma and vitreous fluid levels of dickkopf-1 in patients with diabetic retinopathy. Eye 28:402–409CrossRefPubMedPubMedCentral Qiu F, He J, Zhou Y, Bai X, Wu G, Wang X, Liu Z, Chen Y, Ma JX, Liu Z (2014) Plasma and vitreous fluid levels of dickkopf-1 in patients with diabetic retinopathy. Eye 28:402–409CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Tsentidis C, Gourgiotis D, Kossiva L, Marmarinos A, Doulgeraki A, Karavanaki K (2016) Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density. Pediatr Diabetes 17:289–299CrossRefPubMed Tsentidis C, Gourgiotis D, Kossiva L, Marmarinos A, Doulgeraki A, Karavanaki K (2016) Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density. Pediatr Diabetes 17:289–299CrossRefPubMed
23.
Zurück zum Zitat Tsentidis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, Karavanaki K (2016) Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 27:1631–1643CrossRef Tsentidis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, Karavanaki K (2016) Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 27:1631–1643CrossRef
24.
Zurück zum Zitat Gustafson B, Eliasson B, Smith U (2010) Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor dickkopf-1 in adipocytes: a link with osteogenesis. Diabetologia 53:536–540CrossRefPubMed Gustafson B, Eliasson B, Smith U (2010) Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor dickkopf-1 in adipocytes: a link with osteogenesis. Diabetologia 53:536–540CrossRefPubMed
25.
Zurück zum Zitat Ahmed SF, Fouda N, Abbas AA (2013) Serum dickkopf-1 level in postmenopausal females: correlation with bone mineral density and serum biochemical markers. J Osteoporos 2013:460210CrossRefPubMedPubMedCentral Ahmed SF, Fouda N, Abbas AA (2013) Serum dickkopf-1 level in postmenopausal females: correlation with bone mineral density and serum biochemical markers. J Osteoporos 2013:460210CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Anastasilakis AD, Polyzos SA, Avramidis A, Toulis KA, Papatheodorou A, Terpos E (2010) The effect of teriparatide on serum dickkopf-1 levels in postmenopausal women with established osteoporosis. Clin Endocrinol 72:752–757CrossRef Anastasilakis AD, Polyzos SA, Avramidis A, Toulis KA, Papatheodorou A, Terpos E (2010) The effect of teriparatide on serum dickkopf-1 levels in postmenopausal women with established osteoporosis. Clin Endocrinol 72:752–757CrossRef
27.
Zurück zum Zitat Voskaridou E, Christoulas D, Xirakia C, Varvagiannis K, Boutsikas G, Bilalis A, Kastritis E, Papatheodorou A, Terpos E (2009) Serum dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration Haematologica 94:725–728PubMed Voskaridou E, Christoulas D, Xirakia C, Varvagiannis K, Boutsikas G, Bilalis A, Kastritis E, Papatheodorou A, Terpos E (2009) Serum dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration Haematologica 94:725–728PubMed
28.
Zurück zum Zitat Brunetti G, Faienza M, Piacente L et al (2013) High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment. Am J Physiol Endocrinol Metab 304:E546–E554CrossRefPubMed Brunetti G, Faienza M, Piacente L et al (2013) High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment. Am J Physiol Endocrinol Metab 304:E546–E554CrossRefPubMed
29.
Zurück zum Zitat Mak W, Shao X, Dunstan C, Seibel M, Zhou H (2009) Biphasic glucocorticoid-dependent regulation of wnt expression and its inhibitors in mature osteoblastic cells. Calcif Tissue Int 85:538–545CrossRefPubMed Mak W, Shao X, Dunstan C, Seibel M, Zhou H (2009) Biphasic glucocorticoid-dependent regulation of wnt expression and its inhibitors in mature osteoblastic cells. Calcif Tissue Int 85:538–545CrossRefPubMed
30.
Zurück zum Zitat Butler JS, Queally JM, Devitt BM, Murray DW, Doran PP, O’Byrne JM (2010) Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation. BMC Musculoskelet Disord 11:210CrossRefPubMedPubMedCentral Butler JS, Queally JM, Devitt BM, Murray DW, Doran PP, O’Byrne JM (2010) Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation. BMC Musculoskelet Disord 11:210CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Hameed A, Brady JJ, Dowling P, Clynes M, O’Gorman P (2014) Bone disease in multiple myeloma: pathophysiology and management. Cancer growth and metastasis 7:33–42CrossRefPubMedPubMedCentral Hameed A, Brady JJ, Dowling P, Clynes M, O’Gorman P (2014) Bone disease in multiple myeloma: pathophysiology and management. Cancer growth and metastasis 7:33–42CrossRefPubMedPubMedCentral
Metadaten
Titel
Increased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density
verfasst von
C. Tsentidis
D. Gourgiotis
L. Kossiva
A. Marmarinos
A. Doulgeraki
K. Karavanaki
Publikationsdatum
20.10.2016
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 3/2017
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-016-3802-5

Weitere Artikel der Ausgabe 3/2017

Osteoporosis International 3/2017 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.